https://www.selleckchem.com/ALK.html
SIMPLICITY (NCT0124475 is an observational study of patients with chronic-phase chronic myeloid leukemia (CP-CML) in routine clinical practice receiving first-line tyrosine kinase inhibitors (TKIs). We evaluated TKI treatment changes and how switching affects clinical response in patients recruited in Europe with ≥3years of follow-up. The SIMPLICITY European cohort (France, Germany, Italy, the Netherlands, Russia, and Spain) included 431 patients. 370 (86%) were followed for ≥3years. Proportions of patients experiencing treatment interruptions, TK
Like
Comment
Share
